Sitagliptin Therapy in Hospitalized Patients With Type 2 Diabetes

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 292 participants.

Also called NCT01845831

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 292 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01845831
Other papers using this trial's data
  • Efficacy of sitagliptin for the hospital management of general medicine and surgery patients with type 2 diabetes (Sita-Hospital): a multicentre, prospective, open-label, non-inferiority randomised trial The lancet. Diabetes & endocrinology, 2017-02 DOI, PubMed 27964837 PubMed links an erratum for this paper. Erratum: PMID 28129832; Erratum: PMID 28434492

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01845831. Randomized; no masking; primary purpose treatment. Start 2013-08 (registry gives no type); primary completion 2016-04 (actual). Results posted on 2017-05-30.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Sitagliptin Therapy in Hospitalized Patients With Type 2 Diabetes
Intervention (Drug)
Sitagliptin
Intervention (Drug)
Basal Bolus
Intervention (Drug)
Metformin and Sitagliptin
Intervention (Drug)
Glargine
Intervention (Drug)
Glargine 50%
Intervention (Drug)
Glargine 80%
Lead sponsor
Emory University (class: other)
Collaborator
Merck Sharp & Dohme LLC (class: industry)
Collaborator
Temple University (class: other)
Collaborator
University of Michigan (class: other)
Collaborator
Ohio University (class: other)

Record details

Record id
cardio:ct-nct01845831
Content hash
f8f4a14dc5773c45e82604e504fdc386a32c8ae10087499b0fed3bb3aff4ae2d